Compound rheumatism-rehabilitating composite agent

Abstract

The invention discloses a Chinese medicine preparation for curing rheumatoid arthritis, which is characterized by being prepared from the following raw materials in ratios by weight via the following method: cleaning 12-20% of rhizoma cibotii, 10-14% of zaocys dhumnade, 8-10% of dogwood, 3-6% of astragalus mongholicus, 8-11% of earthworm, 2-4% of scorpio, 6-8% of caulis sinomenii, 6-8% of caulis piperis futokadsurae, 5-7% of herba siegesbeckiae, 3-5% of gentiana macrophylla pall, 3-5% of saposhnikovia divaricata, 3-7% of cassia twig, 2-4% of sinapis seed, 3-6% of radix paeoniae alba, 6-8% of caulis spatholobi, and 3-6% of liquorice, soaking with water, then decocting, removing dregs to obtain a filtrate, sterilizing, and refining to prepare a mixture. The prescription of the compound rheumatism-rehabilitating composite agent disclosed by the invention combines a plurality of medicines, can integrally adjust the immune function of a body, has the functions of resisting inflammation, relieving pain, suppressing immune response and the like, and can effectively treat rheumatoid arthritis.

Description

technical field [0001] The invention relates to the field of pharmaceutical formulations, in particular to a compound Gubikang compound preparation for treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis is a chronic systemic autoimmune disease mainly involving joint lesions. Its onset is slow, the course of the disease and the severity of the joints involved are different. The lesions are continuous and recurrent. The heart, lungs, kidneys, blood vessels and other tissues and organs of the patient's heart, lungs, kidneys, blood vessels and other tissues and organs, the condition can gradually aggravate, and finally it can lead to joint ankylosis, deformity, loss of function and various degrees of disability, which has brought serious harm to the life and health of the patient. There is no specific method for treatment. At present, there is still no method that can completely cure rheumatoid arthritis in the world. The combined drug regimen is ...

AI Technical Summary

Problems solved by technology

There is no specific method for treatment. At present, there is still no method that can completely cure rheumatoid arthritis in the world. The combined drug regimen is non-steroidal anti-inflammatory drugs (NSAIDS) and disease-modifying anti-rheumatic drugs (DMADDS), but these drugs have a slow onset time and sometimes cannot prevent the progression of the disease, and the recurrence rate is high, and finally cannot prevent the disease The progress of the disease caused the joint disability of the patient and brought serious harm to the life and health of the patient.

And long-term application can lead to gastrointestinal reactions, liver function damage, bone marrow suppression and other side effects